|Bid||75.71 x 1100|
|Ask||76.02 x 1100|
|Day's Range||75.81 - 76.19|
|52 Week Range||65.96 - 76.75|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.14%|
Gilead Sciences’ (GILD) tenofovir alafenamide fumarate (or TAF) based regimens have seen high adoption rates in the US and European markets.
Lotus Valve systems are Boston Scientific's (BSX) TAVR (transcatheter aortic valve replacement) range of devices. The device system is approved to be sold in Europe.
Height Securities released its latest analysis of the American Health Care Act Friday following the Congressional Budget Office’s scoring report. Height analyst Stefanie Miller believes the CBO’s scoring ...